Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  New England Journal of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00006254-199801000-00011PMID 9241126
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors.

  1997cited by this paper
• Placental blood transplant: Who will benefit?

  1996cited by this paper
• Patents versus transplants

  1996cited by this paper
• The aging of hematopoietic stem cells

  1996cited by this paper
• High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation.

  1996cited by this paper
• Newborn blood can engraft adult mice without inducing graft-versus-host disease across non H-2 antigens.

  1996cited by this paper
• Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease.

  1996cited by this paper
• Definition of HLA-DQ as a transplantation antigen.

  1996cited by this paper
• Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.

  1996cited by this paper
• Telomerase activity in hematopoietic cells is associated with self-renewal potential.

  1996cited by this paper
• Placental-blood banking--a new frontier in transfusion medicine.

  1996cited by this paper
• Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease.

  1995cited by this paper
• Ethical aspects of banking placental blood for transplantation.

  1995cited by this paper
• Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

  1995cited by this paper
• Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.

  1994cited by this paper
• Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood.

  1994cited by this paper
• Stored placental blood for unrelated bone marrow reconstitution.

  1993cited by this paper
• Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults.

  1992cited by this paper
• Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling.

  1989cited by this paper
• Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.

  1989cited by this paper
• Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings.

  1983cited by this paper
• CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S

  1974cited by this paper

• Umbilical cord milking as a technique to harvest cord blood derived cells for regenerative applications.

  2025cites this paper
• Ex vivo mesenchymal progenitor cell-based cord blood cell expansion and exofucosylation to enhance transplant engraftment.

  2025cites this paper
• Graft Source Choice.

  2025cites this paper
• Outcomes of myeloablative allogeneic hematopoietic cell transplantation with omidubicel vs alternative donor sources

  2025cites this paper
• Impact of hyperbaric oxygen on post-UCB transplant blood transfusion and growth factor support.

  2025cites this paper
• CURRENT USE AND OUTCOMES OF HEMATOPOIETIC CELL TRANSPLANTATION: BRAZILIAN SUMMARY SLIDES – 2025

  2025cites this paper
• Umbilical Cord Blood Transplantation: Revisiting an Overlooked Frontier

  2025cites this paper
• Safety and efficacy of GVHD prophylaxis with mini-dose methotrexate in umbilical cord blood transplantation - NJHSG-CBT18 observational study.

  2025cites this paper
• Development of an umbilical cord blood transplantation–specific nonrelapse mortality risk assessment score

  2024cites this paper
• Single vs double umbilical cord blood transplantation in acute leukemia: Systematic review and meta-analysis.

  2024cites this paper
• Febuxostat-induced agranulocytosis in a pediatric hematopoietic stem cell transplant recipient: Case Report and literature review

  2024cites this paper
• Feasibility of co-transplantation of umbilical cord blood and third-party mesenchymal stromal cells after (non)myeloablative conditioning in patients with hematological malignancies.

  2024cites this paper
• CURRENT USE AND OUTCOMES OF HEMATOPOIETIC STEM CELL TRANSPLANTATION: BRAZILIAN SUMMARY SLIDES – 2024

  2024cites this paper
• Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice

  2023cites this paper
• Long-Term Stability of Cord Blood Units After 29 Years of Cryopreservation: Follow-Up Data From the José Carreras Cord Blood Bank

  2023cites this paper
• The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation

  2023cites this paper
• Regenerative Medicine: Case Study for Understanding and Anticipating Emerging Science and Technology.

  2023cites this paper
• Current use and outcomes of hematopoietic stem cell transplantation: Brazilian summary slides - 2023

  2023cites this paper
• Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future

  2023cites this paper
• Unrelated Donor Cord Blood Transplantation in Children: Lessons Learned Over 3 Decades

  2023cites this paper
• The density of bone marrow mononuclear cells and CD34+ cells in patients with three neurologic conditions

  2023cites this paper
• Single-Nucleotide Polymorphisms Within Non-HLA Regions Are Associated With Engraftment Effectiveness for Patients With Unrelated Cord Blood Transplantation

  2022cites this paper
• Regeneration in Experimental Alveolar Bone Defect Using Human Umbilical Cord Mesenchymal Stem Cells

  2021cites this paper
• Intrabone infusion for allogeneic umbilical cord blood transplantation in children

  2021cites this paper
• [Influence of maternal and infant factors on CD34+ hematopoietic stem/progenitor cells in umbilical cord blood].

  2021cites this paper
• Immunomodulatory Effect of Human Umbilical Cord Blood-derived Mesenchymal Stem Cells on Activated T-lymphocyte.

  2021cites this paper
• Cellular Therapy in Pediatric Hematologic Malignancies.

  2021cites this paper
• Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.

  2021cites this paper
• Optimal umbilical cord blood collection, processing and cryopreservation methods for sustained public cord blood banking.

  2021cites this paper
• Umbilical cord blood transplantation: Still growing and improving

  2021cites this paper
• Cell therapies in the clinic

  2021cites this paper
• Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients

  2021cites this paper
• Conditioning with 10 Gy Total Body Irradiation, Cyclophosphamide, and Fludarabine without ATG Is Associated with Improved Outcome of Cord Blood Transplantation in Children with Acute Leukemia

  2021cites this paper
• Guidelines for Pediatric Unrelated Cord Blood Transplantation-Unique Considerations.

  2021cites this paper
• History of hematopoietic cell transplantation: challenges and progress

  2020cites this paper
• Directed sibling donor cord blood donation in the Chilean Public Health System.

  2020cites this paper
• Reduced dose of MTX for GVHD prophylaxis promotes engraftment and decreases non-relapse mortality in umbilical cord blood transplantation

  2020cites this paper
• Use of the HLA-B leader to optimize cord blood transplantation

  2020cites this paper
• Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study.

  2020cites this paper
• Meta-analysis of hematopoietic stem cell transplantation in major histocompatibility complex class II deficiency.

  2020cites this paper
• Regenerative Medicine and Stem Cell Biology

  2020cites this paper
• Cord blood transplantation for acute leukemia

  2020cites this paper
• Cord blood-derived platelet concentrates as starting material for new therapeutic blood components prepared in a public cord blood bank: from product development to clinical application.

  2020cites this paper
• Preeclampsia in pregnancy affecting the stemness and differentiation potency of haematopoietic stem cell of the umbilical cord blood

  2020cites this paper
• Comparison of Umbilical Cord Blood Transplantation with Bone Marrow or Peripheral Blood Derived Stem-Cell Transplantation in Transfusion Dependent Thalassemia Patients: A Single Center Propensity Score Matching Analysis

  2020cites this paper
• Long‐term Follow‐up of Hematopoietic Stem Cell Transplant Survivors: A Focus on Screening, Monitoring, and Therapeutics

  2020cites this paper
• Substrate Stiffness Directs the Phenotype and Polarization State of Cord Blood Derived Macrophages.

  2020cites this paper
• Evaluation of post‐thaw CFU‐GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant

  2019cites this paper
• Clinical outcomes after allogeneic hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: A report from the Japan Society for Hematopoietic Cell Transplantation.

  2019cites this paper
• Cord blood transplantation for bone marrow failure syndromes: state of art.

  2019cites this paper
• Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients.

  2019cites this paper
• Identification of MicroRNA Related to the CD34+ Cell Fraction of Cord Blood Stem Cells

  2019cites this paper
• The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia.

  2019cites this paper
• Safety and efficacy of ex vivo expanded CD34+ stem cells in murine and primate models

  2019cites this paper
• Lentiviral Gene Therapy for Bone Repair Using Human Umbilical Cord Blood–Derived Mesenchymal Stem Cells

  2019cites this paper
• Utilidad clínica del trasplante de progenitores hematopoyéticos de donantes alternativos en pacientes con hemopatías malignas

  2019cites this paper
• Reduction in Mortality after Umbilical Cord Blood Transplantation in Children Over a 20-Year Period (1995-2014).

  2019cites this paper
• Infectious Complications After Umbilical Cord Blood Transplantation for Hematological Malignancy

  2019cites this paper
• Single nucleotide polymorphisms within HLA region are associated with disease relapse for patients with unrelated cord blood transplantation

  2018cites this paper
• Current Status of Canine Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Veterinary Medicine

  2018cites this paper
• Aldehyde dehydrogenase activity in cryopreserved cord blood cells for quality assessment prior to transplantation.

  2018cites this paper
• Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation.

  2018cites this paper
• Survival after stem-cell transplant in pediatric and young-adult patients with relapsed and refractory B-cell acute lymphoblastic leukemia

  2018cites this paper
• Regenerative medicine in cosmetic dermatology.

  2018cites this paper
• Fast recovery of platelet production in NOD/SCID mice after transplantation with ex vivo expansion of megakaryocyte from cord blood CD34+ cells

  2018cites this paper
• Investigating the genetics ofcord blood transplantation:from classical and non-classical HLAtowards non-HLA genetics and more

  2018cites this paper
• Impaired thymopoiesis predicts for a high risk of severe infections after reduced intensity conditioning without anti-thymocyte globulin in double umbilical cord blood transplantation

  2018cites this paper
• Cell therapy for stress urinary incontinence: Present‐day frontiers

  2018cites this paper
• EBV-PTLD, Adenovirus, and CMV in Pediatric Allogeneic Transplants With Alemtuzumab as Part of Pretransplant Conditioning: A Retrospective Single Center Study

  2018cites this paper
• A Mixture of Mesenchymal Stem Cells from Perinatal Sources Supports Consistent Ex-vivo

  2018cites this paper
• Bone Marrow Harvesting for HSCT

  2018cites this paper
• A comparison of intrauterine hemopoietic cell transplantation and lentiviral gene transfer for the correction of severe β-thalassemia in a HbbTh3/+ murine model

  2018cites this paper
• Study of Aplastic Anaemia, Etiological Role of Environmental and Genetic Factors in Eastern India-A Review

  2018cites this paper
• Best Practices in Processing and Storage for Hematopoietic Cell Transplantation

  2018cites this paper
• Impact of C-rel inhibition of cord blood-derived B-, T-, and NK cells

  2017cites this paper
• From patient centered risk factors to comprehensive prognostic models: a suggested framework for outcome prediction in umbilical cord blood transplantation.

  2017cites this paper
• Cord Blood Transplantations

  2017influential citation
• Quantification of peripheral blood CD34+ cells prior to stem cell harvesting by leukapheresis: a single center experience

  2017cites this paper
• Increase of bone marrow macrophages and CD8+ T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation

  2017cites this paper
• Erythrocyte Membrane-Coated Upconversion Nanoparticles with Minimal Protein Adsorption for Enhanced Tumor Imaging.

  2017cites this paper
• The Impact of High-resolution HLA-A, HLA-B, HLA-C, and HLA-DRB1 on Transplant-related Outcomes in Single-unit Umbilical Cord Blood Transplantation in Pediatric Patients

  2017cites this paper
• The role of policies and networks in development of cord blood usage in China.

  2017cites this paper
• Changing the Paradigm in PRP Characterization: Letter to the Editor

  2017cites this paper
• Human Umbilical Cord Blood Cell Transplantation in Neuroregenerative Strategies

  2017cites this paper
• Clinical Studies of Ex Vivo Expansion to Accelerate Engraftment After Umbilical Cord Blood Transplantation: A Systematic Review.

  2017cites this paper
• The effect of maternal and infant factors on cord blood yield

  2017cites this paper
• How I manage patients with Fanconi anaemia

  2017influential citation
• Perinatal Brain Injury As a Consequence of Preterm Birth and Intrauterine Inflammation: Designing Targeted Stem Cell Therapies

  2017cites this paper
• Synthetic Route Development for the Laboratory Preparation of Eupalinilide E.

  2017cites this paper
• Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation.

  2017cites this paper
• Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood

  2017cites this paper
• Cryopreserved CD34+ Cell Dose, but Not Total Nucleated Cell Dose, Influences Hematopoietic Recovery and Extensive Chronic Graft-versus-Host Disease after Single-Unit Cord Blood Transplantation in Adult Patients.

  2017cites this paper
• Application of Induced Pluripotent Stem Cell Technology to the Study of Hematological Diseases

  2017cites this paper
• The influence of temperature treatment before cryopreservation on the viability and potency of cryopreserved and thawed CD34+ and CD45+ cord blood cells.

  2017cites this paper
• 18 Mesenchymal Stem Cell Therapy for Apoptosis After Spinal Cord Injury

  2017cites this paper
• Late effects of blood and marrow transplantation

  2017cites this paper
• Non-fucosylated CB CD34+ cells represent a good target for enforced fucosylation to improve engraftment following cord blood transplantation.

  2017cites this paper
• Optimization of Unrelated Donor Cord Blood Transplantation for Thalassemia: Implications for Other Non‐Malignant Indications such as HIV Infection or Autoimmune Diseases

  2017cites this paper
• Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT

  2017cites this paper
• In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer

  2017cites this paper